When metformin therapy fails in youth, alternatives are limited to human insulin and liraglutide.
Read More »Semaglutide 2.4 mg Once Weekly for Weight Management in Patients With Or Without T2D
Patients who have obesity but don't have diabetes may now reap the benefits of using a GLP-1 receptor agonist.
Read More »New Innovative Extended Wear Infusion Set
Medtronic recently announced the launch of its new extended infusion set.
Read More »Don’t Blame All Symptoms on Glucose Levels
A woman, 72 years of age, type 2 diabetes, obesity, taking metformin, GLP1, ARB, and antidepressant (SSRI). Lost 20% total body weight in the past year. Recently complaining of dizziness and weakness. Glucose levels in the 60’s at home, at which time had symptoms of hypoglycemia. Glucose-lowering medications (metformin and GLP-1) were stopped. Continued to complain of dizziness and weakness especially in the morning.
Read More »A1C as a Predictor of Mortality in Patients with Diabetes
Can variability in HbA1c lead to a higher risk of mortality in persons with diabetes?
Read More »The Link Between Type 2 Diabetes and Heart Failure
A Mendelian Randomization found a correlation between type 2 diabetes and heart failure, utilizing genetic markers.
Read More »Depression, Its Treatment, and Diabetes Risk
Loss of healthy behaviors due to depression may increase the risk of the development of type 2 diabetes.
Read More »Youth Type 2 Diabetes Linked to a Higher Risk of Diabetes-Related Complications
Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?
Read More »ADA 81st Symposium: Are Point-Of-Care Devices Beneficial in Diagnosing Diabetic Neuropathy?
There is not much evidence-based literature on point-of-care devices, yet they are commonly used for diagnosis.
Read More »ADA 81st Symposium: The Combination of SGLT-2 inhibitors and GLP-1 Receptor Agonists
Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.